Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus  by Kuhn-Nentwig, Lucia et al.
Cupiennin 1d*: the cytolytic activity depends on the hydrophobic
N-terminus and is modulated by the polar C-terminus
Lucia Kuhn-Nentwiga;;1, Margitta Datheb;2, Alfred Walzc;3, Johann Schallerd;4,
Wolfgang Nentwiga;1
aZoological Institute, University of Bern, Baltzerstrasse 6, CH-3012 Bern, Switzerland
bInstitute of Molecular Pharmacology, Robert-Ro«ssle-Str. 10, D-13125 Berlin, Germany
cTheodor Kocher Institute, University of Bern, Freiestr. 1, CH-3012 Bern, Switzerland
dDepartment of Chemistry and Biochemistry, University of Bern, Freiestr. 3, CH-3012 Bern, Switzerland
Received 21 May 2002; revised 29 July 2002; accepted 29 July 2002
First published online 14 August 2002
Edited by Hans Eklund
Abstract To investigate structural features modulating the bio-
logical activity of cupiennin 1 peptides from the spider Cupien-
nius salei, three truncated cupiennin 1d analogs were synthe-
sized. The fact that their growth inhibiting e¡ect on Gram-
negative and Gram-positive bacteria, their lytic activity with
human red blood cells and their insecticidal e¡ect on Drosophila
melanogaster correlates with structural properties shows that
the hydrophobic N-terminal chain segment includes the major
determinants of structure and activity. The polar C-terminus
seems to modulate peptide accumulation at negatively charged
cell surfaces via electrostatic interactions and has no impor-
tant e¡ect on the peptides’ amphipathic secondary struc-
ture. # 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cytolytic peptides [1] are an important component of the
innate immune system of invertebrates [2] and vertebrates [3]
and play a defensive and/or o¡ensive role against external
aggressors. In the hemolymph of arthropods various antimi-
crobial peptides have been identi¢ed as responses to microbial
invasion [2,4^6]. In the venom glands of some insects [7^13],
scorpions [14^19] and spiders [20^22] structurally di¡erent
cytolytic peptides are exclusively and constitutively available.
These polycationic K-helical peptides di¡er considerably in
their amino acids sequences and molecular masses. They all
contain no disul¢de bridges and are linear peptides composed
of 10 to 48 amino acid residues and exhibit di¡erent cytolytic
activities to bacteria, protozoa, fungi and erythrocytes. Some
peptides cause mast cell [9,10,13,18] and granulocytes degra-
nulation [16]. An additional insecticidal activity has been re-
ported for ponericins from the ant Pachycondyla goeldii [12],
oxyopinins and cupiennins from spider venom [21,22].
The only structural exception concerns scorpine from the
venom of Pandinus imperator which is a defensin-like antimi-
crobial peptide composed of 75 amino acid residues and three
disul¢de bridges [15].
Recently, a new family of highly cationic, antimicrobial
peptides has been puri¢ed from the venom of the subtropical
wandering spider Cupiennius salei (Ctenidae) [22]. The cupien-
nin 1 family is constituted by four peptides. The C-terminally
amidated peptides with minor di¡erences in the amino acid
composition consist of 35 residues. In addition to high anti-
bacterial activity the peptides are insecticidal and hemolytic at
micromolar concentrations. The rather unique amphipathic
motif of the potentially helical cupiennin 1 peptides is gener-
ated by a ribbon of charged residues which forms a right
handed spiral on the helix surface. This remarkable charge
distribution starting with Lys7 and ending with Lys32 raises
the question of the functional role of the N- and C-terminal
chain regions of the cupiennins.
Sequence modi¢cation of antimicrobial peptides have been
shown to result in distinct structural modi¢cations and pro-
nounced changes in activity and selectivity [23,24]. Studies of
truncated endogenous peptides have identi¢ed structural de-
terminants and regions with antimicrobial or hemolytic activ-
ity that are much shorter than the parent peptide [25].
In this study we analyzed the role of N- and C-terminal
segments of cupiennin 1d* (cupiennin*: synthesized cupien-
nin) for their antimicrobial, hemolytic and insecticidal activity
as well as for their peptide structure. Our working hypothesis
was that the terminal regions might in£uence helix formation
and modify peptide interaction with di¡erent membrane types
and thus be the crucial factor in the activity spectrum of the
cupiennins.
2. Materials and methods
2.1. Materials
Tri£uoroethanol (TFE) and acetonitrile (LiChrosolv0, for chroma-
tography) were purchased from Merck. 1-Palmitoyl-2-oleoyl phospha-
tidylcholine (POPC) and 1-palmitoyl-2-oleoyl phosphatidyl-DL-glycer-
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ol (POPG) were purchased from Avanti Polar Lipids, Inc., Alabaster,
AL, USA. 9-Fluorenylmethoxy-carbonyl (Fmoc) amino acids were
obtained from Novabiochem (Bad Soden, Germany). All other chem-
icals were of analytical or reagent grade.
2.2. Isolation of cupiennin 1a and peptide synthesis
Venom of C. salei was obtained by means of electrical stimulation
from a permanent breeding line established in our laboratory [26].
Cupiennin 1a was puri¢ed using gel ¢ltration, ion-exchange chroma-
tography and reverse-phase high-performance liquid chromatography
as described [22]. Solid-phase peptide synthesis was performed using
Fmoc chemistry on a Millipore 9050 continuous £ow peptide synthe-
sizer (Millipore Corp., Milford, MA, USA). Peak fractions were pu-
ri¢ed on a semipreparative C18 column (10U250 mm, 7 Wm, 300AL ,
Vydac, Holland, MI, USA). Purity of the cupiennins was assessed by
quantitative amino acid analysis, N-terminal sequence analysis and
electrospray ionization mass spectrometry (ESI-MS; single-stage
quadrupole instrument: VG Platform, Micromass, Manchester, UK).
2.3. Biological activity
Escherichia coli ATCC 25 922, Staphylococcus aureus ATCC 29213,
Enterococcus faecalis ATCC 29212 and Pseudomonas aeruginosa
ATCC 27 853 were cultured in Mueller Hinton broth. The antibacte-
rial activity of the peptides was determined using a microtiter broth
dilution assay [27]. The bacterial inoculum prepared from mid log
phase cultures was diluted to a ¢nal concentration of 1.7^3.8U105
CFU/ml. Peptides (0.04^100 WM), non-treated growth control and a
sterility control were tested in triplicate as described [22].
Peptide (0.08^100 WM) induced hemolysis was determined using
fresh human red blood cells (hRBC). Release of hemoglobin was
monitored by changes in the absorbance at 541 nm (Jasco,V-550,
Japan). The positive control (100% hemolysis) was human erythro-
cytes in water and the negative control (0% hemolysis) was human
erythocytes in phosphate bu¡ered saline as described in [22]. The
peptide concentration inducing 50% hemolysis (EC50) was derived
from dose response curves using sigmoidal curve ¢tting software
(Graph Pad Prism, 3.0; Graph Pad Software, Inc. USA).
Drosophila melanogaster were used to determine the insecticidal
activity of the peptides (1^400 pmol/mg £y). Each of three peptide
concentrations was tested on 20 £ies and the same number of £ies was
used as control (injecting 0.05 Wl of insect ringer). Calculations of the
lethal doses LD50 (50% of the test £ies died of intoxication 24 h post
injection) were performed as mentioned elsewhere [28].
2.4. Circular dichroism (CD) measurements
For CD measurements aliquots of the peptide solutions (prepared
in 5 mM Na2HPO4/NaH2PO4 bu¡er, pH 7.2 containing 150 mM
NaF) were diluted with bu¡er or TFE or mixed with aliquots of a
suspension of small unilamellar vesicles (SUVs) to give a ¢nal peptide
concentration of 50 WM and the desired solvent composition or lipid
to peptide molar ratio (Cl/Cp). SUVs were prepared as described
[29]. Measurements were performed in 0.1 cm cells between 195 and
260 nm at room temperature using a J 720 spectrometer (Jasco, Ja-
pan). The helicity (error 5%) was calculated from the band intensity at
222 nm according to Chen et al. [30].
3. Results
3.1. Peptide design and structural features
Three cupiennin 1d peptides were synthesized, structurally
characterized and compared with cupiennin 1a, the most
abundant cupiennin 1 in the venom of C. salei [22] (Fig.
1A). Cupiennin 1d* (ESI-MS 3794.65O 0.44, theoretically
3795.55 Da) is an analog of the natural cupiennin 1d with
Gln at the non-amidated C-terminus instead of the amidated
C-terminal Glu. Cupiennin 1d*C (ESI-MS 2694.74O 0.20, the-
oretically 2695.25 Da) was generated by deletion of nine ami-
no acid residues at the cupiennin 1d* C-terminus. Cupiennin
1d*NC (ESI-MS 2233.11O 0.06, theoretically 2233.73 Da) rep-
resents the 6^26 central region of cupiennin 1d* lacking the
N-terminal penta- and C-terminal nonapeptide.
Elimination of the C-terminal nonapeptide reduced the cat-
ionic peptide charge by +2. As a consequence, the angle (x) of
220‡ subtended by the cationic residues in cupiennin 1d* de-
creases to 160‡ for the truncated derivatives (Fig. 1B). Simul-
taneously, the peptide hydrophobicity (H) calculated on the
basis of the Eisenberg consensus scale of hydrophobicity for
Fig. 1. Amino acid sequence and K-helical wheel projection of cupiennins. A: Comparison of the amino acid sequences of cupiennin 1a, and
the synthetic cupiennins 1d*, 1d*C and 1d*NC. Amino acid exchanges between cupiennin 1a and 1d are boxed. B: Helical wheel projection of
cupiennin 1d*, 1d*C and 1d*NC. Polar amino acids are marked with dashed circles and lysine residues with black circles. x is the denoted angle
subtended by the cationic residues and given together with the net charge of the peptides in the center of the wheel.
FEBS 26452 30-8-02
L. Kuhn-Nentwig et al./FEBS Letters 527 (2002) 193^198194
Table 1
Structural properties of cupiennin 1a, 1d*, 1d*C and 1d*NC
Peptide Number of
residues
Molecular
mass (Da)
Net chargea x (deg)b Hc Wc K (%)d (TFE 30%) K (%)d (TFE 50%) K (%) POPG K (%) POPC
Cl /Cp = 52 Cl/Cp = 260 Cl/Cp = 52 Cl/Cp = 260
Cupiennin 1a 35 3798.59 +8 220 30.138 0.0226 94 100 99 100 5 21
Cupiennin 1d* 35 3795.55 +8 220 30.152 0.0282 100 100 100 96 5 23
Cupiennin 1d*C 26 2695.25 +6 160 30.095 0.0738 98 100 87 83 3 26
Cupiennin 1d*NC 21 2233.73 +6 160 30.175 0.1160 77 84 40 41 0 1
aThe net charge of the cupiennins was calculated assuming that His is not charged under physiological conditions.
bx is the angle subtended by the cationic residues on the helix surface of the cupiennins.
cThe mean hydrophobicity, H, and the hydrophobic moment, W, were calculated using the Eisenberg consensus scale [31].
dThe helicity, K, of the cupiennins (50 WM; in phosphate bu¡er 30% and 50% TFE) was calculated according to [30].
Table 2
Bactericidal, hemolytic and insecticidal activity of cupiennins 1a, 1d*, 1d*C and 1d*NC
Peptide Bactericidal activity MICa (WM) Hemolytic activity Insecticidal activity
E. coli (ATCC 25922)
3.1U105 CFUb/ml
P. aeruginosa (ATCC
27853) 3.8U105 CFU/ml
S. aureus (ATCC 29213)
2.6U105 CFU/ml
E. faecalis (ATCC 29212)
1.7U105 CFU/ml
EC50c (WM) LD50d (pmol/mg £y)
Cupiennin 1ae 0.31^0.63 0.63^1.25 0.63^1.25 2.50^5.00 24.4 (22.9^26.0) 5.9 (4.2^8.3)
Cupiennin 1d*e 0.31^0.63 0.31^0.63 0.31^0.63 1.25^2.50 14.5 (14.4^14.7) 7.9 (6.4^9.9)
Cupiennin 1d*C 1.25^2.50 0.63^1.25 10^20 s 20 50.4 (49.7^51.1) 30.7 (28.7^33.0)
Cupiennin 1d*NC s 160 s 160 s 160 s 160 s 100 s 400
aThe minimal inhibitory concentration (MIC) of cupiennins was determined by a liquid growth assay after 24 h. MIC’s are expressed as ¢nal concentration intervals [a]3[b], where [a] is the high-
est concentration at which bacteria are growing and [b] is the lowest concentration causing 100% growth inhibition.
bCFU, colony forming units.
cHemolytic activity (EC50) was determined as the percentage of released hemoglobin spectroscopically measured at 541 nm after 1 h incubation at 37‡C.
dInsecticidal activity (LD50) was checked in a bioassay on D. melanogaster where peptides were dissolved in insect ringer and 0.05 Wl injected into the £ies.
eData from [22].
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the individual amino acid residues [31] increased from 30.152
for cupiennin 1d* to 30.095 for cupiennin 1d*C. Conversely,
elimination of the more hydrophobic N-terminal part reduced
H of cupiennin 1d*NC to 30.175. The mean hydrophobic mo-
ment, W, follows the order: 1d*NC (0.116)s 1d*C
(0.0738)s 1d* (0.0282) (Table 1).
3.2. Biological activity
The activities of cupiennin 1a and 1d* were similar. Com-
pared to cupiennin 1d*, the antimicrobial activity of cupien-
nin 1d*C decreased by one dilution step for P. aeruginosa
(0.63^1.25 WM) and by two dilution steps for E. coli (1.25^
2.50 WM). The susceptibility of the Gram-positive bacteria
S. aureus (10^20 WM) and E. faecalis (s 20 WM) to cupiennin
1d*C di¡ered by three to ¢ve dilution steps compared with
cupiennin 1d*. Cupiennin 1d*NC was inactive up to the tested
concentration of 160 WM (Table 2). The hemolytic activity
followed the order: cupiennin 1d* (14.5 WM)s 1d*C (50.4
WM)s 1d*NC (s 100 WM). The insecticidal e¡ects on D. me-
lanogaster showed the same pattern. Compared to cupiennin
1d*, the activity of cupiennin 1d*C was reduced by a factor of
about four and no activity was found for cupiennin 1d*NC
administration below 400 pmol/mg £y (Table 2).
3.3. Conformational studies
CD spectra of the peptides in TFE and in the presence of
lipid vesicles were recorded to determine the ability of the
peptides to assume a helical conformation and to obtain in-
formation about their a⁄nity to lipid bilayer. All sequences
are highly £exible in bu¡er (Fig. 2). Addition of TFE resulted
in helix formation. The spectra of cupiennin 1a, 1d* and 1d*C
re£ect complete helicity while K of 1d*NC was found to reach
only 84% in bu¡er/TFE (1/1, v/v) (Table 1). The helical order:
cupiennin 1d*v 1d*Cv 1as 1d*NC correlated with the order
derived from a secondary structure prediction method yield-
ing helicities of cupiennin 1d* (71%)s 1d*C (69%)s 1a
(54%)s 1d*NC (52%) [32].
All peptides strongly interact with negatively charged
POPG vesicles. The lipid bound cupiennin 1a, 1d* and 1d*C
revealed very high helicity while cupiennin 1d*NC was at 40%
much less helical (Table 1, Fig. 2). The data correlated with
the helical propensity. Additionally, the low K of cupiennin
1d*NC has to be associated with the reduced hydrophobicity
of the fragment and strong electrostatic interactions with the
charged lipid head groups which inhibit peptide interaction
with the hydrophobic region of the lipid bilayer [29]. Hydro-
phobic interactions between peptide side chains and lipid acyl
Fig. 2. CD spectra of cupiennin 1a, 1d*, 1d*C and 1d*NC in bu¡er (solid line) (5 mM sodium phosphate, 150 mM sodium £uoride, pH 7.2)
and in the presence of POPC and POPG^SUVs. The lipid concentration (Cl) is 50 WM. The lipid to peptide molar ratio is 52 (dotted line) and
260 (dashed line). 3 is the mean ellipticity per residue.
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chains appear to be the primary forces driving structure for-
mation on model membranes [33]. The a⁄nity of cupiennin
1a, 1d* and 1d*C to POPC vesicles is low, therefore electro-
static interactions do not play a role. The slight increase of K
with increasing lipid to peptide ratio led to the assumption
that even at Cl/Cp = 260 only a small amount of peptide was
in the vesicle bound state. The least hydrophobic cupiennin
1d*NC did not bind at all under the conditions used (Table 1,
Fig. 2).
4. Discussion
Studies of a variety of natural peptides and chemically
modi¢ed analogs suggest that the two step process of mem-
brane permeation, accumulation of the peptides at the mem-
brane surface and insertion into the lipid layer, depends on
the lipid composition of the target cells and is distinctly
modulated by the structural properties of the peptides [34^
36]. The importance of cationic peptide charge consists in
the recognition of negatively charged bacterial membranes
and high peptide accumulation on the membrane surface lead-
ing to membrane disruption. The e¡ective permeabilization of
neutral membranes depends more on a deep penetration of
peptides into the hydrophobic membrane interior. Thus, the
e¡ect is closely related to peptide hydrophobicity, amphipa-
thicity, quanti¢ed by the hydrophobic moment and the size of
hydrophobic domains [37,38].
Many antimicrobial peptides occur in the C-terminus ami-
dated form and their lytic activity decreases when the C-ter-
minal amide is removed [39,40]. Our studies show that the
exchange of the C-terminal, amidated Glu of cupiennin 1a
against Gln in the 1d* analog has minor consequences for
this activity. The activities are clearly related to nearly iden-
tical structural features: the peptides have the same size, their
global charge is identical, H and W are comparable and pep-
tide helicities are indistinguishable.
All investigated peptides possess high a⁄nity to negatively
charged lipid matrices as revealed by CD spectroscopy. Thus,
high peptide accumulation on the highly cationic outer mem-
brane of Gram-negative bacteria resulting in an e¡ective self
promoted uptake [1] may provide the basis for the pro-
nounced activity of cupiennin 1a, 1d* and 1d*C. Moderate
intrinsic hydrophobicity and a non-charged N-terminal seg-
ment seem to be responsible for the permeabilization of the
inner target membrane after binding via electrostatic interac-
tions. Electrostatic interactions also drive peptide binding to
the negatively charged lipid matrix of Gram-positive bacteria.
In contrast to Gram-negative bacteria, the e¡ect is more
strongly modulated by the global peptide charge. Impaired
binding with reduction of charge from +8 to +6 might be
one explanation for the more than 10-fold reduced activity
of cupiennin 1d*C towards S. aureus and E. faecalis compared
with cupiennin 1d*. Disturbed amphipathicity due to a
slightly reduced helicity of the lipid bound peptide (Table 1)
may additionally decrease its insertion into the membrane.
The low activity of cupiennin 1d*NC towards bacterial strains
underlines the important role of the hydrophobic N-terminal
pentapeptide for the biological e¡ect. This activity pattern
correlates with structural characteristics. N-terminal trunca-
tion conferred pronounced hydrophilicity on the remaining
fragment, thus reducing the contribution of hydrophobic in-
teractions to activity. Furthermore, helix formation was ham-
pered and the related reduction of the theoretically high hy-
drophobic moment had an additional activity impairing e¡ect.
The highly cationic peptides also displayed substantial ac-
tivity towards the neutral lipid matrix of eukaryotic cells,
where the e¡ect is determined by hydrophobic peptide mem-
brane interactions. The activity pattern, which was compara-
ble to that towards prokaryotic cells, points to a dominating
role of the hydrophobic N-terminal pentapeptide. Its insertion
into the lipid matrix generates membrane lysis; its elimination
results in drastically reduced activity. Structure^activity stud-
ies on cecropin A showed a loss in antibacterial activity by
deletion of the ¢rst two N-terminal amino acids [41]. Deletion
of the three N-terminal amino acids of magainin-2 amide
caused a slight decrease of antibacterial activity but removal
of the four N-terminal amino acids resulted in a dramatic
decrease in activity [42]. Melittin reveals an activity pattern
comparable to cupiennins. After reduction of the ¢rst seven
hydrophobic N-terminal amino acid residues the remaining 8^
26 melittin peptide failed to lyse membranes [43,44]. Actually,
the nature of the peptides is similar : the N-terminal part of
the chain is highly hydrophobic. Surprisingly, despite en-
hanced H and W, the hemolytic and insecticidal activities of
cupiennin 1d*C were reduced by a factor of about three to
four compared to the parent analog. One reason might by a
slightly reduced helicity of the lipid bound peptide (Table 1)
which results in a disturbed amphipathicity and reduced hy-
drophobic interactions.
In conclusion, cupiennin 1d* and its truncated analogs were
ideal objects for assessing the structural implications of the
peptide characteristics and the e¡ects of these on the various
peptide activities. These studies show that the major determi-
nant of structure and activity of the cupiennin 1 peptides is
located in the hydrophobic N-terminal chain segment. The
role of the charged C-terminus consists in modulating peptide
accumulation at negatively charged cell surfaces via electro-
static interactions rather than modifying the amphipathic sec-
ondary structure of the peptides.
Acknowledgements: We thank J. Mu«ller, H. Petrenko and H. Niko-
lenko for their excellent technical assistance, Dr. T. Bodmer for kindly
providing the bacteria and Dr. H. Murray for critical reading of the
manuscript. This research was supported by the Swiss National Sci-
ence Foundation.
References
[1] Hancock, R.E. and Lehrer, R. (1998) Trends Biotechnol. 16, 82^
88.
[2] Hetru, C., Ho¡mann, D. and Bulet, P. (1998) in: Molecular
Mechanisms of Immune Responses in Insects (Brey, P.T. and
Hultmark, D., Eds.), pp. 40^66, Chapman and Hall, London.
[3] Lehrer, R.I. and Ganz, T. (1999) Curr. Opin. Immunol. 11, 23^
27.
[4] Ehret-Sabatier, L., Loew, D., Goy¡on, M., Fehlbaum, P., Ho¡-
mann, J.A., van Dorsselaer, A. and Bulet, P. (1996) J. Biol.
Chem. 271, 29537^29544.
[5] Cociancich, S., Goy¡on, M., Bontems, F., Bulet, P., Bouet, F.,
Menez, A. and Ho¡mann, J. (1993) Biochem. Biophys. Res.
Commun. 194, 17^22.
[6] Silva, P.I., Da¡re, S. and Bulet, P. (2000) J. Biol. Chem. 275,
33464^33470.
[7] Habermann, E. and Jentsch, J. (1967) Hoppe-Seyler’s Z., Physiol.
Chem. 348, 37^50.
[8] Fennell, J.F., Shipman, W.H. and Cole, L.J. (1968) Proc. Soc.
Exp. Biol. Med. 127, 707^710.
FEBS 26452 30-8-02
L. Kuhn-Nentwig et al./FEBS Letters 527 (2002) 193^198 197
[9] Argiolas, A. and Pisano, J.J. (1984) J. Biol. Chem. 259, 10106^
10111.
[10] Argiolas, A. and Pisano, J.J. (1985) J. Biol. Chem. 260, 1437^
1444.
[11] Ho, C.-L. and Hwang, L.-L. (1991) Biochem. J. 274, 453^456.
[12] Orivel, J., Redeker, V., Le Caer, J.-P., Krier, F., Revol-Junelles,
A.-M., Longeon, A., Cha¡otte, A., Dejean, A. and Rossier, J.
(2001) J. Biol. Chem. 276, 17823^17829.
[13] Konno, K., Hisada, M., Fontana, R., Lorenzi, C.C., Naoki, H.,
Itagaki, Y., Miwa, A., Kawai, N., Nakata, Y., Yasuhara, T.,
Neto, J.R., de Azevedo Jr., W.F., Palma, M.S. and Nakajima,
T. (2001) Biochim. Biophys. Acta 1550, 70^80.
[14] Torres-Larios, A., Gurrola, G.B., Zamudio, F.Z. and Possani,
L.D. (2000) Eur. J. Biochem. 267, 5023^5031.
[15] Conde, R., Zamudio, F.Z., Rodr|¤guez, M.H. and Possani, L.D.
(2000) FEBS Lett. 471, 165^168.
[16] Verdonck, F., Bosteels, S., Desmet, J., Moerman, L., Noppe, W.,
Willems, J., Tytgat, J. and Walt, J. (2000) Cimbebasia 16, 247^
260.
[17] Corzo, G., Escoubas, P., Villegas, E., Barnham, K.J., He, W.L.,
Norton, R.S. and Nakajima, T. (2001) Biochem. J. 359, 35^45.
[18] Dai, L., Yasuda, A., Naoki, H., Corzo, G., Andriantsiferana, M.
and Nakajima, T. (2001) Biochem. Biophys. Res. Commun. 286,
820^825.
[19] Dai, L., Corzo, G., Naoki, H., Andriantsiferana, M. and Naka-
jima, T. (2002) Biochem. Biophys. Res. Commun. 293, 1514^
1522.
[20] Yan, L. and Adams, M.E. (1998) J. Biol. Chem. 273, 2059^2066.
[21] Corzo, G., Villegas, E., Gomez-Lagunas, F., Possani, L.D., Be-
lokoneva, O.S. and Nakajima, T. (2002) J. Biol. Chem. 277,
23627^23637.
[22] Kuhn-Nentwig, L., Mu«ller, J., Schaller, J., Walz, A., Dathe, M.
and Nentwig, W. (2002) J. Biol. Chem. 277, 11208^11216.
[23] Subbalakshmi, C., Nagaraj, R. and Sitaram, N. (1999) FEBS
Lett. 448, 62^66.
[24] Oren, Z. and Shai, Y. (1996) Eur. J. Biochem. 237, 303^310.
[25] Mor, A. and Nicolas, P. (1994) J. Biol. Chem. 269, 1934^1939.
[26] Kuhn-Nentwig, L., Schaller, J. and Nentwig, W. (1994) Toxicon
32, 287^302.
[27] Wu, M. and Hancock, R.E.W. (1999) J. Biol. Chem. 274, 29^35.
[28] Kuhn-Nentwig, L., Schaller, J., Ka«mpfer, U., Imboden, H., Mal-
li, H. and Nentwig, W. (2000) Arch. Insect Biochem. Physiol. 44,
101^111.
[29] Dathe, M., Schu«mann, M., Wieprecht, T., Winkler, A., Beyer-
mann, M., Krause, E., Matsuzaki, K., Murase, O. and Bienert,
M. (1996) Biochemistry 35, 12612^12622.
[30] Chen, Y.-H., Yang, J.T. and Martinez, H.M. (1972) Biochemis-
try 11, 4120^4131.
[31] Eisenberg, D. (1984) Annu. Rev. Biochem. 53, 595^623.
[32] Garnier, J., Gibrat, J.-F. and Robson, B. (1996) Methods Enzy-
mol. 266, 540^553.
[33] Blondelle, S.E., Forood, B., Houghten, R.A. and Pe¤rez-Paya¤, E.
(1997) Biopolymers 42, 489^498.
[34] Sitaram, N. and Nagaraj, R. (1999) Biochim. Biophys. Acta
1462, 29^54.
[35] Shai, Y. (1999) Biochim. Biophys. Acta 1462, 55^70.
[36] Dathe, M. (2000) in: Membrane Structure in Diseases and Drug
Therapy (Zimmer, G., Ed.), pp. 1^26, Marcel Dekker, New
York, Basel.
[37] Dathe, M. and Wieprecht, T. (1999) Biochim. Biophys. Acta
1462, 71^87.
[38] Dathe, M., Meyer, J., Beyermann, M., Maul, B., Hoischen, C.
and Bienert, M. (2002) Biochim. Biophys. Acta 1558, 171^186.
[39] Maloy, W.L. and Kari, U.P. (1995) Biopolymers 37, 105^122.
[40] Kitamura, A., Kiyota, T., Lee, S. and Sugihara, G. (1998) Bull.
Chem. Soc. Jpn. 71, 1151^1158.
[41] Andreu, D., Merri¢eld, R.B., Steiner, H. and Boman, H.G.
(1985) Biochemistry 24, 1683^1688.
[42] Zaslo¡, M., Martin, B. and Chen, H.-C. (1988) Proc. Natl. Acad.
Sci. USA 85, 910^913.
[43] Dawson, C.R., Drake, A.F., Helliwell, J. and Hider, R.C. (1978)
Biochim. Biophys. Acta 510, 75^86.
[44] Saberwal, G. and Nagaraj, R. (1994) Biochim. Biophys. Acta
1197, 109^131.
FEBS 26452 30-8-02
L. Kuhn-Nentwig et al./FEBS Letters 527 (2002) 193^198198
